Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
· Financial Post
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Read More
Visit asg-reflektory.pl for more information.